Structures by: Salazar-Pereda V.
Total: 14
C36H47AuBN8,C5H8N2
C36H47AuBN8,C5H8N2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 19 6199-6204
a=11.3365(3)Å b=11.3427(3)Å c=17.7686(6)Å
α=71.578(3)° β=80.431(2)° γ=80.447(2)°
C36H46AuBN8
C36H46AuBN8
Dalton transactions (Cambridge, England : 2003) (2020) 49, 19 6199-6204
a=10.7562(4)Å b=12.2016(4)Å c=16.3263(5)Å
α=92.925(3)° β=97.466(3)° γ=115.809(4)°
C42H58AuBN8
C42H58AuBN8
Dalton transactions (Cambridge, England : 2003) (2020) 49, 19 6199-6204
a=10.6045(4)Å b=11.9711(4)Å c=20.2522(8)Å
α=97.609(3)° β=102.029(3)° γ=93.076(3)°
C18H19AuIN3
C18H19AuIN3
New Journal of Chemistry (2018) 42, 19 15533
a=9.62530(10)Å b=11.0961(2)Å c=17.7617(2)Å
α=90° β=94.0600(10)° γ=90°
C36H38AuN6,C30H44B2KN12
C36H38AuN6,C30H44B2KN12
New Journal of Chemistry (2018) 42, 19 15533
a=14.1732(3)Å b=15.6010(3)Å c=19.7007(5)Å
α=76.639(2)° β=73.137(2)° γ=89.372(2)°
C36H38AuN6,2(C15H22BK0.5N6)
C36H38AuN6,2(C15H22BK0.5N6)
New Journal of Chemistry (2018) 42, 19 15533
a=14.7835(3)Å b=15.7197(3)Å c=16.7848(4)Å
α=82.050(2)° β=83.870(2)° γ=87.964(2)°
C32H35BCl2IrN7O
C32H35BCl2IrN7O
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16878-16888
a=13.6084(4)Å b=14.7870(4)Å c=16.1275(4)Å
α=87.0120(10)° β=85.0970(10)° γ=89.1360(10)°
2(C35H41BClIrN8O3),1.5(C6H14)
2(C35H41BClIrN8O3),1.5(C6H14)
Dalton transactions (Cambridge, England : 2003) (2016) 45, 42 16878-16888
a=10.5090(6)Å b=18.6526(10)Å c=20.9424(12)Å
α=87.867(2)° β=77.420(2)° γ=81.622(2)°
C24H36BIrN6O2
C24H36BIrN6O2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 31 13881-13889
a=12.9841(2)Å b=14.2878(2)Å c=14.0320(3)Å
α=90° β=97.2716(15)° γ=90°
C22H34BIrN6O2
C22H34BIrN6O2
Dalton transactions (Cambridge, England : 2003) (2015) 44, 31 13881-13889
a=10.6560(9)Å b=17.2090(16)Å c=14.1376(13)Å
α=90° β=102.549(2)° γ=90°
C20H25BBr5IrN6O2,C6H14
C20H25BBr5IrN6O2,C6H14
Dalton transactions (Cambridge, England : 2003) (2015) 44, 31 13881-13889
a=11.8577(5)Å b=16.3125(7)Å c=18.7394(8)Å
α=90° β=103.2370(10)° γ=90°
2-(4-Bromophenyl)-1-(4-nitrophenyl)-1<i>H</i>-benzimidazole
C19H12BrN3O2
Acta Crystallographica Section C (2014) 70, 1 55-59
a=7.8689(4)Å b=10.0444(4)Å c=11.8867(5)Å
α=68.534(4)° β=76.677(4)° γ=86.869(4)°
Carbonyl(3-oxopenta-1,4-diene-1,5,-diyl)[tris(3,5-dimethyl-1<i>H</i>- pyrazol-1-yl-κ<i>N</i>^2^)methane]iridium(III) trifluoromethanesulfonate
C22H26IrN6O2,CF3O3S
Acta Crystallographica Section C (2012) 68, 12 m367-m369
a=13.1441(3)Å b=16.2686(2)Å c=14.0631(3)Å
α=90° β=115.506(3)° γ=90°
1,2-Bis(4-bromophenyl)-1<i>H</i>-benzimidazole
C19H12Br2N2
Acta Crystallographica Section C (2014) 70, 1 55-59
a=7.6621(5)Å b=10.8241(7)Å c=11.0422(7)Å
α=105.078(6)° β=106.456(6)° γ=96.677(5)°